Australia markets closed

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.67-0.01 (-0.04%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 860.72M
Enterprise value 379.25M
Trailing P/E 1.84k
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)29.91
Price/book (mrq)2.32
Enterprise value/revenue 14.06
Enterprise value/EBITDA -2.24

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 315.31%
S&P500 52-week change 322.64%
52-week high 328.91
52-week low 312.54
50-day moving average 323.86
200-day moving average 320.33

Share statistics

Avg vol (3-month) 3404.68k
Avg vol (10-day) 3392.76k
Shares outstanding 537.97M
Implied shares outstanding 636.71M
Float 8N/A
% held by insiders 16.17%
% held by institutions 1104.76%
Shares short (15 Apr 2024) 42.96M
Short ratio (15 Apr 2024) 47.04
Short % of float (15 Apr 2024) 48.58%
Short % of shares outstanding (15 Apr 2024) 47.80%
Shares short (prior month 15 Mar 2024) 42.56M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,017.35%

Management effectiveness

Return on assets (ttm)-23.60%
Return on equity (ttm)-56.31%

Income statement

Revenue (ttm)26.98M
Revenue per share (ttm)0.76
Quarterly revenue growth (yoy)67.40%
Gross profit (ttm)N/A
EBITDA -183.4M
Net income avi to common (ttm)-180.66M
Diluted EPS (ttm)-5.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)526.42M
Total cash per share (mrq)12.36
Total debt (mrq)44.96M
Total debt/equity (mrq)12.12%
Current ratio (mrq)8.08
Book value per share (mrq)8.74

Cash flow statement

Operating cash flow (ttm)-60.63M
Levered free cash flow (ttm)-75.43M